Syngen Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 27, 2022 at 06:37 pm EDT
Share
Syngen Biotech Co.,Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 378.68 million compared to TWD 305.41 million a year ago. Net income was TWD 65.33 million compared to TWD 41.41 million a year ago. Basic earnings per share from continuing operations was TWD 2.41 compared to TWD 1.53 a year ago. Diluted earnings per share from continuing operations was TWD 2.41 compared to TWD 1.53 a year ago.
Syngen Biotech Co Ltd is a Taiwan-based company mainly engaged in the manufacture and distribution of active pharmaceutical ingredients and health food products. The Companyâs products mainly consist of active pharmaceutical ingredients, health food raw materials, medical equipment, such as bone density analyzers, blood glucose analyzers and biochemical analyzers, as well as animal health products and others. The Company distributes its products mainly in Taiwan, Iran, South Korea and Egypt.